2Young NS, Calado RT. Current concepts in pathophysiology and treatment of aplastie anemia. Blood,2006,108:2509.
3Maciejewski JP, O' keefe C, Gondek L. Immune-mediated bone marrow failure syndromes of progenitor and stem cells: molecular analysis of cytotoxic T cell clones. Folia Histochem Cytobio1,2007, 45:5-14.
4Marsh J. Making therapeutic decisions in adults with aplastic anemia. Hematology Am Soc Hematol Educ Program,2006:78-85.
5Frickhofen N, Resenfold SJ, Immunosupressive treatment of aplastic anemia with antithymocyte globulin and eycloseprine. Semin Hematol,2000,37:56-68.
6Scheinberg P, Nunez O, Young NS. Treatment of severe aplastic anaemia with combined immunosuppression : anti-thymocyte globulin, ciclosporin and mycophenolate mofetil. Br J Haematol, 2006,133:606-611.
7Marsh JC. Treatment of acquired aplastic anemia. Haematologica, 2007,92:2-5.
8Scheinberg P, Wu CO, Nunez O, et al. Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine. J Pediatr,2008,153:29.
9Chandra J, Naithani R, Ravi R,et al. Antithymocyte globulin and cyclosporin in children with acquired aplastic anemia. Indian J Pediatr,2008, 75:229-233.
